Publications

A combined genomic arrhythmia propensity score delineates cumulative risk

 33
A combined genomic arrhythmia propensity score delineates cumulative risk

Tags:

Previous Article

ALS treatment using RNA-based gene therapy

Next Article

Genetic testing trifecta predicts risk of sudden cardiac death and arrhythmia

Related Posts

Targeting the peripheral neural-tumour microenvironment for cancer therapy

Targeting the peripheral neural-tumour microenvironment...

 110

Transcriptional control of natural killer cell antitumor activity

Transcriptional control of natural killer cell antitumo...

 74

Loss of p300 in proximal tubular cells reduces renal fibrosis and endothelial-mesenchymal transition

Loss of p300 in proximal tubular cells reduces renal fi...

 89